BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 3116772)

  • 1. Diagnostic value of thyrotropin-releasing-hormone stimulation in patients with pituitary tumor.
    Cook DM; Greer MA; Paxton H
    West J Med; 1987 Aug; 147(2):161-4. PubMed ID: 3116772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of abnormal dopaminergic control of prolactin in patients with hypothalamic and pituitary tumors.
    Cabranes JA; Almoguera I; del Olmo J; Prensa A; Pablos I; Charro AL
    J Med; 1986; 17(1):25-39. PubMed ID: 3035040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combined pituitary function test in children: an evaluation of the clinical usefulness of TRH and LHRH stimulation tests through a retrospective analysis of one hundred and twenty six cases.
    Westwood ME; Butler GE; McLellan AC; Barth JH
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):727-33. PubMed ID: 10848877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulpiride and thyrotrophin releasing hormone loading test in patients with acromegaly.
    Zséli J; Földes J; Holló I; Kollin E; Horváth C; Gács G; Borvendég J
    Acta Med Acad Sci Hung; 1980; 37(4):357-64. PubMed ID: 6785978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of growth of carcinogen-induced mammary cancers in rats by thyrotropin-releasing hormone.
    Chen HJ; Bradley CJ; Meites J
    Cancer Res; 1977 Jan; 37(1):64-6. PubMed ID: 401473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenomas of patients with acromegaly express thyrotropin-releasing hormone receptor messenger RNA: cloning and functional expression of the human thyrotropin-releasing hormone receptor gene.
    Yamada M; Monden T; Satoh T; Satoh N; Murakami M; Iriuchijima T; Kakegawa T; Mori M
    Biochem Biophys Res Commun; 1993 Sep; 195(2):737-45. PubMed ID: 8396925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
    Snyder PJ; Utiger RD
    J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic-pituitary function following bromocriptine therapy in patients with prolactinomas.
    Badawy SZ; Notman DD; Sunderlin FS; Springer JM; Streeten DH; Omar MM; Marshall LD
    J Reprod Med; 1982 Mar; 27(3):139-45. PubMed ID: 6806469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum thyrotropin responses to synthetic thyrotropin-releasing hormone in normal children and hypopituitary patients. A new test to distinguish primary releasing hormone deficiency from primary pituitary hormone deficiency.
    Foley TP; Owings J; Hayford JT; Blizzard RM
    J Clin Invest; 1972 Feb; 51(2):431-7. PubMed ID: 4621544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone and prolactin release after injection of thyrotropin-releasing hormone in patients with depression.
    Maeda K; Kato Y; Ohgo S; Chihara K; Yoshimoto Y; Yamaguchi N; Kuromaru S; Imura H
    J Clin Endocrinol Metab; 1975 Mar; 40(3):501-5. PubMed ID: 803976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The value of functional tests in diagnosis of prolactinoma].
    Klockenbusch W; Distler W; von Ditfurth M; Graf M; Jahn K
    Geburtshilfe Frauenheilkd; 1990 May; 50(5):383-7. PubMed ID: 2115483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of pituitary hormones: clinical applications. 5. Prolactin.
    Donald RA; Espiner EA; Hodgkinson SC; Evans K
    N Z Med J; 1976 Jun; 83(566):431-5. PubMed ID: 9604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress: differential regulation of adrenocorticotropin hormone and alpha-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone.
    Rotllant J; Balm PH; Ruane NM; Pérez-Sánchez J; Wendelaar-Bonga SE; Tort L
    Gen Comp Endocrinol; 2000 Aug; 119(2):152-63. PubMed ID: 10936035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of allogeneic bone marrow transplantation (BMT) on pituitary, gonad, thyroid and adrenal function in adults.
    Kauppila M; Koskinen P; Irjala K; Remes K; Viikari J
    Bone Marrow Transplant; 1998 Aug; 22(4):331-7. PubMed ID: 9722067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin dynamics and tumour size in the prediction of surgical outcome for prolactinoma.
    Gordon D; Richards A; Bulloch R; Cohen HN; Semple CG; Beastall GH; Thomson JA; Teasdale G
    Q J Med; 1985 Feb; 54(214):141-51. PubMed ID: 3920723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations of thyroxine, 3,5,3'-triiodothyronine, thyrotropin, and prolactin in dogs before and after thyrotropin-releasing hormone administration.
    Kaufman J; Olson PN; Reimers TJ; Allen TA; Soderberg SF; Nett TM; Wheeler SL; Wingfield WE
    Am J Vet Res; 1985 Feb; 46(2):486-92. PubMed ID: 3922262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [GH and PRL after TRH and hpGRF(1-40) administration in 2 cases of acromegaly with hyperprolactinemia].
    Sampaolo G; Faloia E; Sarzani R; Bartolacci V; Schiavo P; Butini L; Morosini P
    Recenti Prog Med; 1987 Mar; 78(3):115-8. PubMed ID: 3110882
    [No Abstract]   [Full Text] [Related]  

  • 20. Is idiopathic hyperprolactinemia a transitional stage toward prolactinoma?
    Pereira MC; Sobrinho LG; Afonso AM; Ferreira JM; Santos MA; Sousa MF
    Obstet Gynecol; 1987 Sep; 70(3 Pt 1):305-8. PubMed ID: 3114691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.